Recommended Topic Related To:

Fluorometholone Forte

"Researchers at the National Eye Institute (NEI) have found a unique cell type that, in tests on mice, can protect against uveitis—a group of inflammatory diseases that affect the eye and can cause vision loss.

Uveitis occurs when "...

FML Forte

How Supplied


FML FORTE® (fluorometholone ophthalmic suspension 0.25%) suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.


Instill one drop into the conjunctival sac two to four times daily. Care should be taken not to discontinue therapy prematurely.

If signs and symptoms fail to improve after two days, the patient should be re-evaluated (see PRECAUTIONS).

The dosing of FML FORTE® (fluorometholone ophthalmic suspension 0.25%) suspension may be reduced, but care should be taken not to discontinue therapy prematurely. In chronic conditions, withdrawal of treatment should be carried out by gradually decreasing the frequency of applications.


FML FORTE® (fluorometholone ophthalmic suspension, USP) 0.25% is supplied sterile in opaque white LDPE plastic bottles with droppers with white high impact polystyrene (HIPS) caps as follows:

10 mL in 15 mL bottle - NDC 11980-228-10

5 mL in 10 mL bottle - NDC 11980-228-05

15 mL in 15 mL bottle - NDC 11980-228-15

Note: Store at or below 25°C (77°F); protect from freezing. Shake well before using.

Revised June 2004. Allergan Inc. Irvine, CA 92612, U.S.A. FDA Rev date: 01/10/06

Last reviewed on RxList: 7/30/2008
This monograph has been modified to include the generic and brand name in many instances.

How Supplied

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

WebMD Daily

Get breaking medical news.